These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35831249)

  • 21. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Wang Y; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis.
    Yoshimatsu Y; Naganuma M; Sugimoto S; Tanemoto S; Umeda S; Fukuda T; Nomura E; Yoshida K; Ono K; Mutaguchi M; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Takabayashi K; Ogata H; Iwao Y; Kanai T
    Digestion; 2020; 101(4):492-498. PubMed ID: 31238326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK; Wang JJ
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases.
    Merra G; Gasbarrini G; Laterza L; Pizzoferrato M; Poscia A; Scaldaferri F; Arena V; Fiore F; Cittadini A; Sgambato A; Franceschi F; Gasbarrini A
    World J Gastroenterol; 2012 Sep; 18(36):5065-71. PubMed ID: 23049215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study.
    Ito H; Iida M; Matsumoto T; Suzuki Y; Sasaki H; Yoshida T; Takano Y; Hibi T
    Inflamm Bowel Dis; 2010 Sep; 16(9):1567-74. PubMed ID: 20049950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etrolizumab for induction of remission in ulcerative colitis.
    Rosenfeld G; Parker CE; MacDonald JK; Bressler B
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011661. PubMed ID: 26630451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose infliximab for treatment of pediatric ulcerative colitis: a survey of clinical practice.
    Nattiv R; Wojcicki JM; Garnett EA; Gupta N; Heyman MB
    World J Gastroenterol; 2012 Mar; 18(11):1229-34. PubMed ID: 22468086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease.
    Singh N; Rabizadeh S; Jossen J; Pittman N; Check M; Hashemi G; Phan BL; Hyams JS; Dubinsky MC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2121-6. PubMed ID: 27542130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
    Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin for maintenance of remission in ulcerative colitis.
    Kumar S; Ahuja V; Sankar MJ; Kumar A; Moss AC
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008424. PubMed ID: 23076948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qing Dai attenuates nonsteroidal anti-inflammatory drug-induced mitochondrial reactive oxygen species in gastrointestinal epithelial cells.
    Saito R; Tamura M; Matsui H; Nagano Y; Suzuki H; Kaneko T; Mizokami Y; Hyodo I
    J Clin Biochem Nutr; 2015 Jan; 56(1):8-14. PubMed ID: 25678747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics for maintenance of remission in ulcerative colitis.
    Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study.
    Iwańczak BM; Kierkuś J; Ryżko J; Szczepanik M; Więcek S; Czaja-Bulsa G; Kacperska M; Korczowski B; Maślana J; Iwańczak F
    Adv Clin Exp Med; 2017; 26(1):57-61. PubMed ID: 28397433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis.
    Iizuka M; Etou T; Shimodaira Y; Hatakeyama T; Sagara S
    World J Gastroenterol; 2021 Mar; 27(12):1194-1212. PubMed ID: 33828394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.